Actively Recruiting
Impact of Help-Seeking Behaviors on Allergic Rhinitis, Asthma Control, and Mental Health: A Retrospective and Longitudinal Analysis of Allergy Medication Use
Led by QHSLab, Inc. · Updated on 2026-02-11
200000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research investigates how seeking help for emotional well-being and allergies affects the management of allergic rhinitis, asthma, and mental health symptoms like anxiety and depression. By analyzing both past and ongoing patient data, the study focuses on patients diagnosed with allergic rhinitis and mental health conditions. It aims to stress the importance of combining mental health care with allergy treatments to improve overall patient health. The study looks at how patients use allergy medications such as intranasal steroids, antihistamines, decongestants, and leukotriene blockers, and how these treatments relate to both allergy and mental health symptoms. It assesses help-seeking behaviors to understand their role in controlling symptoms, using validated tools like the SNOT-22 for allergic rhinitis and PHQ-GAD16 for mental health. The research uses real-world data to explore coordinated care approaches. Participants' symptom severity is monitored through yearly evaluations over a period of up to five years. The main outcome measured is the change in allergic rhinitis symptoms using the SNOT-22 score. Secondary outcomes include changes in depression and anxiety symptoms using PHQ-9 and GAD-7 scores. The study collects data retrospectively and longitudinally to assess how integrated care impacts symptom control and quality of life.
CONDITIONS
Brief Title
Impact of Help-Seeking Behaviors on Allergic Rhinitis and Mental Health: A Longitudinal Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (aged 18 years or older)
- Patients actively receiving care in a primary care setting
- Patients who have provided informed consent for their health data to be included in the research repository
You will not qualify if you...
- Patients who have not provided informed consent for their health data to be included in the research repository
- Patients diagnosed with chronic conditions outside the scope of allergic rhinitis, asthma, or mental health conditions (anxiety, depression)
- Patients with severe mental health disorders or comorbidities unrelated to the study conditions, such as schizophrenia or bipolar disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Up to 5 years
Participants are observed over time to assess the impact of help-seeking behaviors and allergy medication use on allergic rhinitis, asthma control, and mental health outcomes.
Annual visits for up to 5 years
Trial Site Locations
Total: 1 location
1
QHSLab
West Palm Beach, Florida, United States, 33407
Actively Recruiting
Research Team
M
Marcos A Sanchez-Gonzalez, MD, PhD
T
Troy Grogan
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here